Analysts Set Sage Therapeutics, Inc. (NASDAQ:SAGE) Target Price at $8.81
Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) has received a consensus recommendation of “Hold” from the nineteen ratings firms that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating on the company. […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) has received a consensus recommendation of “Hold” from the nineteen ratings firms that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating on the company. […]
